Evaluating ultrasound-guided pleural drainage in ICU patients with respiratory failure
Official title: Drainage of Pleural Effusions in the Intensive Care Unit in Adults With Respiratory Failure: A Randomised Clinical Feasibility Trial of Performing Versus Withholding Pleural Drainage
Run by Aalborg University Hospital · NCT06709456 · Data updated 2026-11-12
This study is testing if using ultrasound to help drain fluid from the lungs can improve the health of adults in the ICU who are struggling to breathe.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 88 (estimated) |
| Sponsor | Aalborg University Hospital Academic / other |
| Locations | 6 sites (Aalborg and 5 other locations) |
| Status | Recruiting |
| Started | December 2, 2024 |
| Main results expected | October 2025 |
| Study ends | October 2025 |
| Registry record updated | April 11, 2025 |
| Trial ID | NCT06709456 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who are admitted to the ICU with pleural effusions of at least 2 cm and respiratory failure.
✕Probably not a fit
Patients with existing pleural drains, suspected or confirmed haemothorax, or pneumothorax may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial assesses the feasibility of performing ultrasound-guided pleural drainage in adult ICU patients suffering from pleural effusions and respiratory failure. Participants will be randomly assigned to either receive drainage or not, unless their condition deteriorates. The study will measure various outcomes, including the proportion of patients receiving drainage, adherence to the protocol, and clinical outcomes such as mortality and serious adverse events over a 90-day period. The aim is to determine if a larger, definitive trial on this intervention is feasible.
Why it matters
Potential benefit: If successful, this study could provide insights into the effectiveness of pleural drainage in improving outcomes for ICU patients with respiratory failure.
How similar studies have gone: There is limited evidence and no prior randomized trials specifically addressing this intervention in ICU patients with respiratory failure, making this approach relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Acute admission to the ICU. * Age ≥ 18 years. * Pleural effusion ≥ 2 cm in either pleural cavity assessed by ultrasonography, computed tomography or magnetic resonance imaging (measured between the parietal and visceral pleura perpendicularly to the chest wall at the largest-separation point). * Respiratory failure defined as one or more of the following: any oxygen supplementation in an open system, invasive or non-invasive mechanical ventilation (including non-intermittent mask CPAP), or most recent arterial blood gas analysis with arterial partial pressure of carbon dioxide (PaCO2) \> 6.0 kPa and pH \< 7.35. Exclusion Criteria: * Mediastinal drain or pleural drain in situ on either side. * Suspected or confirmed haemothorax (e.g., due to recent thoracic trauma or intrathoracic surgery). * Suspected or confirmed pneumothorax (e.g., by anamnesis, on radiographic or ultrasonographic assessment, or by clinical presentation, e.g., due to presence of subcutaneous emphysema). * Suspected or confirmed pleural empyema (e.g., by anamnesis or clinical presentation, or on CT, MRI or ultrasonographic assessment). * Pleural malignancy (suspected or confirmed pleural lymphoma, pleural metastases or direct pleural invasion, or malignant mesothelioma). * Antithrombotic treatment or coagulation deficiency incompatible with conducting pleural drainage as by local recommendations, and contraindications to reversal of this (clinical assessment). * Clinically assessed absolute indication for therapeutic pleural drainage and: * invasive or non-invasive mechanical ventilation or mask CPAP with PaO2/FiO2 ratio ≤ 13.3 kPa in the most recent ABG analysis. * high-flow humidified oxygen therapy with a flow ≥ 50 L/min and a PaO2/FiO2 ratio ≤ 13.3 kPa in the most recent ABG analysis. * persistent respiratory acidosis with a pH \< 7.25 and a PaCO2 \> 6.0 kPa in the most recent ABG analysis in spite of non-invasive ventilation for \> 1 hour. * Withdrawal from active therapy or brain death deemed imminent. * Expected ICU stay \< 24 hours from randomisation. * Pregnancy (in females \< 60 years of age, non-pregnancy must be confirmed by a negative urine or plasma human chorionic gonadotropin, or presence a condition incompatible with pregnancy, e.g., previous hysterectomy, or conducted caesarean section during current hospitalisation). * Under coercive measures (i.e., ongoing involuntary hospital admission or under correctional authorities' jurisdiction). * Consent not obtainable as per Danish legislation. * Previously randomised in the DOPE-ICU feasibility trial.
Where it's running
-
Department of Anaesthesia and Intensive Care, Aalborg University Hospital
Aalborg, Denmark Recruiting -
ICU department 4131, Copenhagen University Hospital, Rigshospitalet
Copenhagen, Denmark Recruiting -
Department of Anaesthesia and Intensive Care, Nordsjællands Hospital, University of Copenhagen, Hillerød
Hillerød, Denmark Recruiting -
Department of Anaesthesiology and Intensive Care Medicine, Sygehus Lillebælt, Kolding
Kolding, Denmark Recruiting -
Department of Anaesthesia and Intensive Care, Zealand University Hospital, Køge
Køge, Denmark Not yet recruiting -
Department of Anaesthesia and Intensive Care, Zealand University Hospital, Roskilde
Roskilde, Denmark Not yet recruiting
Study contacts
- Principal investigator: Olav L Schjørring, MD, PhD — Department of Anaesthesia and Intensive Care, Aalborg University Hospital, Denmark
- Study coordinator: Marie S Worm, MD
- Email: marie.worm@rn.dk
- Phone: +45 97 66 19 24
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Diagnosing malignant pleural effusion with the EPISEEK-MPE liquid biopsy
A test called EPISEEK-MPE is being checked to see if it can tell cancer from non-cancer pleural effusions using fluid already removed for care.
-
HFNC During Bronchoscopy for Respiratory Failure
This study tests whether using high-flow nasal oxygen during fiber-optic bronchoscopy is safe and helpful for patients with respiratory failure.
-
Respiratory progression in adults with Duchenne muscular dystrophy: a long-term observational study
This study tests how respiratory function changes over three years in adults with genetically confirmed Duchenne muscular dystrophy.
-
Epidural spinal cord stimulation to help breathing after cervical spinal cord injury
This trial tests whether adding epidural spinal cord stimulation to standard care can improve breathing in adults with cervical spinal cord injury and respiratory failure.
-
Brain blood flow and brain regulation in critically ill kids
This study tests how blood flow in the brain behaves in critically ill children using a noninvasive ultrasound (TCD) to see if brain autoregulation patterns relate to outcomes.
-
Ciprofol versus propofol for sedating adult ICU patients on noninvasive respiratory support
See if ciprofol works better than propofol for sedating adults in the ICU who are receiving noninvasive ventilation, high-flow nasal cannula, or oxygen therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.